Ex-Allergan President Escapes Investor Suit Over Exec Pay
By Lana Birbrair ( February 9, 2012, 4:56 PM EST) -- The former president of Allergan Inc. was dismissed Thursday from a shareholder derivative suit accusing the company's board of directors of issuing a misleading statement requesting approval of a defective executive compensation plan that cost the pharmaceutical company millions in tax benefits....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.